BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 32060055)

  • 1. High-MYC Cells Depend on NUAK1 to Prevent Stalled Transcription.
    Cancer Discov; 2020 Apr; 10(4):485. PubMed ID: 32060055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription.
    Cossa G; Roeschert I; Prinz F; Baluapuri A; Silveira Vidal R; Schülein-Völk C; Chang YC; Ade CP; Mastrobuoni G; Girard C; Wortmann L; Walz S; Lührmann R; Kempa S; Kuster B; Wolf E; Mumberg D; Eilers M
    Mol Cell; 2020 Mar; 77(6):1322-1339.e11. PubMed ID: 32006464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splice or Die: When MYC Is Driving, Transcription Needs NUAK1 to Avoid Fatal Pileups.
    Fisher RP
    Mol Cell; 2020 Mar; 77(6):1157-1158. PubMed ID: 32200795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion.
    Chen P; Li K; Liang Y; Li L; Zhu X
    Exp Lung Res; 2013 Feb; 39(1):9-17. PubMed ID: 23215946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
    Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F
    Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation.
    Hou X; Liu JE; Liu W; Liu CY; Liu ZY; Sun ZY
    Oncogene; 2011 Jun; 30(26):2933-42. PubMed ID: 21317932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output.
    Kolliopoulos C; Raja E; Razmara M; Heldin P; Heldin CH; Moustakas A; van der Heide LP
    J Biol Chem; 2019 Mar; 294(11):4119-4136. PubMed ID: 30622137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
    Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
    Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUAK1 inhibition prevents fibrosis.
    Crunkhorn S
    Nat Rev Drug Discov; 2022 May; 21(5):338. PubMed ID: 35388207
    [No Abstract]   [Full Text] [Related]  

  • 10. MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
    Shi L; Zhang B; Sun X; Lu S; Liu Z; Liu Y; Li H; Wang L; Wang X; Zhao C
    Br J Cancer; 2014 Dec; 111(12):2316-27. PubMed ID: 25412236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.
    Tang YC; Ho SC; Tan E; Ng AWT; McPherson JR; Goh GYL; Teh BT; Bard F; Rozen SG
    Breast Cancer Res; 2018 Mar; 20(1):22. PubMed ID: 29566768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1.
    Yu Y; Wang Y; Xiao X; Cheng W; Hu L; Yao W; Qian Z; Wu W
    Biochem Cell Biol; 2019 Oct; 97(5):563-570. PubMed ID: 30807203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell.
    Lan X; Liu X
    J Cell Mol Med; 2019 Apr; 23(4):2351-2361. PubMed ID: 29575772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized inhibition of protein phosphatase 1 by NUAK1 promotes spliceosome activity and reveals a MYC-sensitive feedback control of transcription.
    Cossa G; Roeschert I; Prinz F; Baluapuri A; Vidal RS; Schülein-Völk C; Chang YC; Ade CP; Mastrobuoni G; Girard C; Kumar A; Wortmann L; Walz S; Lührmann R; Kempa S; Kuster B; Wolf E; Mumberg D; Eilers M
    Mol Cell; 2021 Jun; 81(11):2495. PubMed ID: 34087181
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of NUAK1 and NUAK2 expression during early chick development reveals specific patterns in the developing head.
    Bekri A; Billaud M; Thélu J
    Int J Dev Biol; 2014; 58(5):379-84. PubMed ID: 25354459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR‑96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer.
    Huang X; Lv W; Zhang JH; Lu DL
    Int J Mol Med; 2014 Dec; 34(6):1599-605. PubMed ID: 25242509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUAK1 links genomic instability and senescence.
    Bernard D; Augert A
    Aging (Albany NY); 2010 Jun; 2(6):317-9. PubMed ID: 20603521
    [No Abstract]   [Full Text] [Related]  

  • 19. Haploinsufficiency of autism spectrum disorder candidate gene NUAK1 impairs cortical development and behavior in mice.
    Courchet V; Roberts AJ; Meyer-Dilhet G; Del Carmine P; Lewis TL; Polleux F; Courchet J
    Nat Commun; 2018 Oct; 9(1):4289. PubMed ID: 30327473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUAK1 promotes kidney fibrosis.
    Carney EF
    Nat Rev Nephrol; 2022 Jun; 18(6):345. PubMed ID: 35484398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.